US74365N2027 - Common Stock
PROTAGENIC THERAPEUTICS INC
NASDAQ:PTIX (3/28/2024, 8:00:01 PM)
After market: 1.61 -0.14 (-8%)1.75
-0.07 (-3.85%)
Protagenic Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in New York City, New York. The firm specializes in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide (TCAP), an endogenous brain signaling peptide that can dampen overactive stress responses. Its lead compound is a 41-residue peptide synthetic TCAP-1. In addition, it has a portfolio of earlier stage neuropeptides targeting the TCAP pathway that are in preclinical evaluation. PT00114 has also demonstrated pre-clinical efficacy in a murine model of opioid withdrawal called the Saleens test. Its preclinical models have demonstrated the efficacy of PT00114 in animal models of depression, anxiety, substance abuse and addiction, and PTSD.
PROTAGENIC THERAPEUTICS INC
149 Fifth Avenue, Suite 500
New York City NEW YORK 10010
P: 12129948200
CEO: Garo H. Armen
Employees: 0
Website: https://protagenic.com/
Protagenic Therapeutics (PTIX) on Wednesday announced it has approved a 1-for-4 reverse stock split of the company's issued and outstanding common stock.
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!
NEW YORK, NY / ACCESSWIRE / April 26, 2022 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) a biopharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders, today announced will be presenting at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference tomorrow, April 27, 2022. The presentation details are as follows: Date: Wednesday, April 27, 2022 Time: 10:30 AM ET Link:
Here you can normally see the latest stock twits on PTIX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: